Literature DB >> 26531754

A Decision Tree Based Classifier to Analyze Human Ovarian Cancer cDNA Microarray Datasets.

Meng-Hsiun Tsai1,2, Hsin-Chieh Wang3, Guan-Wei Lee4, Yi-Chen Lin5, Sheng-Hsiung Chiu6.   

Abstract

Ovarian cancer is the deadliest gynaecological disease because of the high mortality rate and there is no any symptom in cancer early stage. It was often the terminal cancer period when patients were diagnosed with ovarian cancer and thus delays a good opportunity of treatment. The current common method for detecting ovarian cancer is blood testing for analyzing the tumor marker CA-125 of serum. However, specificity and sensitivity of CA-125 are insufficient for early detection. Therefore, it has become an urgent issue to look for an efficient method which precisely detects the tumor markers for ovarian cancer. This study aims to find the target genes of ovarian cancer by different algorithms of information science. Feature selection and decision tree were applied to analyze 9600 ovarian cancer-related genes. After screening the target genes, candidate genes will be analyzed by Ingenuity Pathway Analysis (IPA) software to create a genetic pathway model and to understand the interactive relationship in the different pathological stages of ovarian cancer. Finally, this research found 9 oncogenes associated with ovarian cancer and some genes had not been discovered in previous studies. This system will assist medical staffs in diagnosis and treatment at cancer early stage and improve the patient's survival.

Entities:  

Keywords:  C&RT; CHAID; Decision tree; Ingenuity Pathway Analysis; Ovarian cancer

Mesh:

Substances:

Year:  2015        PMID: 26531754     DOI: 10.1007/s10916-015-0361-9

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  29 in total

1.  Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.

Authors:  Andrea Li-Ann Wong; Hui-Ling Yap; Wee-Lee Yeo; Richie Soong; Swee-Siang Ng; Ling-Zhi Wang; Maricel Tiemsim Cordero; Wei-Peng Yong; Boon-Cher Goh; Soo-Chin Lee
Journal:  Cancer Genomics Proteomics       Date:  2011 Sep-Oct       Impact factor: 4.069

Review 2.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation.

Authors:  Yumiko Oishi; Ichiro Manabe; Kazuyuki Tobe; Kensuke Tsushima; Takayuki Shindo; Katsuhito Fujiu; Go Nishimura; Koji Maemura; Toshimasa Yamauchi; Naoto Kubota; Ryo Suzuki; Toshio Kitamura; Shizuo Akira; Takashi Kadowaki; Ryozo Nagai
Journal:  Cell Metab       Date:  2005-01       Impact factor: 27.287

4.  KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.

Authors:  Ceshi Chen; Hina V Bhalala; Robert L Vessella; Jin-Tang Dong
Journal:  Prostate       Date:  2003-05-01       Impact factor: 4.104

5.  Intestinal tumor progression is associated with altered function of KLF5.

Authors:  Nicholas W Bateman; Dongfeng Tan; Richard G Pestell; Jennifer D Black; Adrian R Black
Journal:  J Biol Chem       Date:  2004-01-15       Impact factor: 5.157

Review 6.  Oncogenic mechanisms in Burkitt lymphoma.

Authors:  Roland Schmitz; Michele Ceribelli; Stefania Pittaluga; George Wright; Louis M Staudt
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

7.  The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

Authors:  Beatrice Mohelnikova-Duchonova; Veronika Brynychova; Viktor Hlavac; Matej Kocik; Martin Oliverius; Jan Hlavsa; Eva Honsova; Jan Mazanec; Zdenek Kala; Bohuslav Melichar; Pavel Soucek
Journal:  Cancer Chemother Pharmacol       Date:  2013-08-11       Impact factor: 3.333

8.  Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients.

Authors:  Anusri Tripathi; Chialin King; Antonio de la Morenas; Victoria Kristina Perry; Bohdana Burke; Gregory A Antoine; Erwin F Hirsch; Maureen Kavanah; Jane Mendez; Michael Stone; Norman P Gerry; Marc E Lenburg; Carol L Rosenberg
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

9.  Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients.

Authors:  X-Y Dong; X-A Yang; Y-D Wang; W-F Chen
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.

Authors:  Erin K Crane; Suet-Yan Kwan; Daisy I Izaguirre; Yvonne T M Tsang; Lisa K Mullany; Zhifei Zu; JoAnne S Richards; David M Gershenson; Kwong-Kwok Wong
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

View more
  4 in total

1.  An Improved CAD System for Breast Cancer Diagnosis Based on Generalized Pseudo-Zernike Moment and Ada-DEWNN Classifier.

Authors:  Satya P Singh; Shabana Urooj
Journal:  J Med Syst       Date:  2016-02-18       Impact factor: 4.460

2.  EGR-1 plays a protective role in AMPK inhibitor compound C-induced apoptosis through ROS-induced ERK activation in skin cancer cells.

Authors:  Kai-Cheng Chuang; Fan-Wen Chen; Meng-Hsiun Tsai; Jeng-Jer Shieh
Journal:  Oncol Lett       Date:  2021-02-19       Impact factor: 2.967

3.  Building a Personalized Cancer Treatment System.

Authors:  Alexandra Martinez; Gustavo López; Constantino Bola Nos; Daniel Alvarado; Andrés Solano; Mariana López; Andrés Báez; Steve Quirós; Rodrigo Mora
Journal:  J Med Syst       Date:  2016-12-27       Impact factor: 4.460

4.  An Optimized Framework for Cancer Prediction Using Immunosignature.

Authors:  Fatemeh Safaei Firouzabadi; Alireza Vard; Mohammadreza Sehhati; Mohammadreza Mohebian
Journal:  J Med Signals Sens       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.